A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncolo
about
A Phase II feasibility study of oral etoposide given concurrently with radiotherapy followed by dose intensive adjuvant chemotherapy for children with newly diagnosed high-risk medulloblastoma (protocol POG 9631): A report from the Children's Oncolo
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Phase II feasibility study o ...... ort from the Children's Oncolo
@en
A Phase II feasibility study o ...... osed high-risk medulloblastoma
@nl
type
label
A Phase II feasibility study o ...... ort from the Children's Oncolo
@en
A Phase II feasibility study o ...... osed high-risk medulloblastoma
@nl
prefLabel
A Phase II feasibility study o ...... ort from the Children's Oncolo
@en
A Phase II feasibility study o ...... osed high-risk medulloblastoma
@nl
P2093
P2860
P356
P1476
A Phase II feasibility study o ...... ort from the Children's Oncolo
@en
P2093
Adam J Esbenshade
Albert Moghrabi
Amar Gajjar
Jean-Claude Decarie
Linda Hershon
Peter Burger
Pierre Rousseau
Susan Shaw
P2860
P356
10.1002/PBC.26373
P577
2016-12-21T00:00:00Z